Xingjun Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xingjun Zhu has a total of 132 co-authors. Here are the top co-authors by number of shared publications:
Qian Hu
17 shared publicationsJieying Zhang
11 shared publicationsLingkai Meng
10 shared publicationsNa Kong
School of Physical Science and Technology, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai, 201210, P. R. China
10 shared publicationsSixin Xu
School of Physical Science and Technology ShanghaiTech University Shanghai China
9 shared publicationsZhenyu Xing
School of Physical Science and Technology ShanghaiTech University Shanghai China
8 shared publications
Latest Publications
- 6 November 2026
- Published by Wiley in Angewandte Chemie
Intrinsic Redox‐Responsive NIR‐II Lanthanide Luminescent Nanoprobes Enabled by Phonon‐Assisted Cooperative Quenching for Reversible Redox Imaging In Vivo
Lanthanide nanoparticles (LnNPs) are photostable second near‐infrared window (NIR‐II) emitters well suited to long‐term redox imaging. However, responsive LnNP nanoprobes generally require surface‐installed molecular recognition components to transduce chemical changes into luminescence signals, which may introduce additional functionalization complexity and compromise long‐term signal reliability. Here, we identify a redox‐regulated phonon‐assisted cooperative quenching (PACQ) phenomenon in NaCeF 4 :Nd, where Ce(III)/Ce(IV) conversion modulates Nd(III) emission through lattice‐mediated interactions. To elucidate this intrinsic response, a model NaLuF 4 @NaCeF 4 :Nd architecture was constructed to expose the NaCeF 4 :Nd shell and reveal the underlying PACQ mechanism. Oxidation‐induced changes in Ce electronic configuration and local lattice environment weaken Ce‐mediated quenching and restore NIR‐II Nd(III) emission. Based on this mechanism, we further develop a ratiometric NaErF 4 :Yb@NaLuF 4 @NaCeF 4 :Nd nanoprobe (RPACQ), where the Er(III) emission provides a stable internal reference. RPACQ exhibits reversible H 2 O 2 /glutathione responses, with second‐scale activation, concentration‐dependent ratiometric responses in vitro, and excellent photostability. In a cerebral ischemia‐reperfusion injury (CIRI) model, RPACQ provides proof‐of‐concept for in vivo redox imaging. Collectively, this work establishes an intrinsic lanthanide nanoparticle strategy for reversible NIR‐II luminescence regulation without external molecular reporters, potentially opening new avenues for engineering responsive lanthanide nanomaterials.
- 6 November 2026
- Published by Wiley in Angewandte Chemie
Intrinsic Redox‐Responsive NIR‐II Lanthanide Luminescent Nanoprobes Enabled by Phonon‐Assisted Cooperative Quenching for Reversible Redox Imaging In Vivo
Lanthanide nanoparticles (LnNPs) are photostable second near‐infrared window (NIR‐II) emitters well suited to long‐term redox imaging. However, responsive LnNP nanoprobes generally require surface‐installed molecular recognition components to transduce chemical changes into luminescence signals, which may introduce additional functionalization complexity and compromise long‐term signal reliability. Here, we identify a redox‐regulated phonon‐assisted cooperative quenching (PACQ) phenomenon in NaCeF 4 :Nd, where Ce(III)/Ce(IV) conversion modulates Nd(III) emission through lattice‐mediated interactions. To elucidate this intrinsic response, a model NaLuF 4 @NaCeF 4 :Nd architecture was constructed to expose the NaCeF 4 :Nd shell and reveal the underlying PACQ mechanism. Oxidation‐induced changes in Ce electronic configuration and local lattice environment weaken Ce‐mediated quenching and restore NIR‐II Nd(III) emission. Based on this mechanism, we further develop a ratiometric NaErF 4 :Yb@NaLuF 4 @NaCeF 4 :Nd nanoprobe (RPACQ), where the Er(III) emission provides a stable internal reference. RPACQ exhibits reversible H 2 O 2 /glutathione responses, with second‐scale activation, concentration‐dependent ratiometric responses in vitro, and excellent photostability. In a cerebral ischemia‐reperfusion injury (CIRI) model, RPACQ provides proof‐of‐concept for in vivo redox imaging. Collectively, this work establishes an intrinsic lanthanide nanoparticle strategy for reversible NIR‐II luminescence regulation without external molecular reporters, potentially opening new avenues for engineering responsive lanthanide nanomaterials.
- 6 November 2026
- Published by Wiley in Angewandte Chemie International Edition
Intrinsic Redox‐Responsive NIR‐II Lanthanide Luminescent Nanoprobes Enabled by Phonon‐Assisted Cooperative Quenching for Reversible Redox Imaging In Vivo
Lanthanide nanoparticles (LnNPs) are photostable second near‐infrared window (NIR‐II) emitters well suited to long‐term redox imaging. However, responsive LnNP nanoprobes generally require surface‐installed molecular recognition components to transduce chemical changes into luminescence signals, which may introduce additional functionalization complexity and compromise long‐term signal reliability. Here, we identify a redox‐regulated phonon‐assisted cooperative quenching (PACQ) phenomenon in NaCeF 4 :Nd, where Ce(III)/Ce(IV) conversion modulates Nd(III) emission through lattice‐mediated interactions. To elucidate this intrinsic response, a model NaLuF 4 @NaCeF 4 :Nd architecture was constructed to expose the NaCeF 4 :Nd shell and reveal the underlying PACQ mechanism. Oxidation‐induced changes in Ce electronic configuration and local lattice environment weaken Ce‐mediated quenching and restore NIR‐II Nd(III) emission. Based on this mechanism, we further develop a ratiometric NaErF 4 :Yb@NaLuF 4 @NaCeF 4 :Nd nanoprobe (RPACQ), where the Er(III) emission provides a stable internal reference. RPACQ exhibits reversible H 2 O 2 /glutathione responses, with second‐scale activation, concentration‐dependent ratiometric responses in vitro, and excellent photostability. In a cerebral ischemia‐reperfusion injury (CIRI) model, RPACQ provides proof‐of‐concept for in vivo redox imaging. Collectively, this work establishes an intrinsic lanthanide nanoparticle strategy for reversible NIR‐II luminescence regulation without external molecular reporters, potentially opening new avenues for engineering responsive lanthanide nanomaterials.
- 6 November 2026
- Published by Wiley in Angewandte Chemie International Edition
Intrinsic Redox‐Responsive NIR‐II Lanthanide Luminescent Nanoprobes Enabled by Phonon‐Assisted Cooperative Quenching for Reversible Redox Imaging In Vivo
Lanthanide nanoparticles (LnNPs) are photostable second near‐infrared window (NIR‐II) emitters well suited to long‐term redox imaging. However, responsive LnNP nanoprobes generally require surface‐installed molecular recognition components to transduce chemical changes into luminescence signals, which may introduce additional functionalization complexity and compromise long‐term signal reliability. Here, we identify a redox‐regulated phonon‐assisted cooperative quenching (PACQ) phenomenon in NaCeF 4 :Nd, where Ce(III)/Ce(IV) conversion modulates Nd(III) emission through lattice‐mediated interactions. To elucidate this intrinsic response, a model NaLuF 4 @NaCeF 4 :Nd architecture was constructed to expose the NaCeF 4 :Nd shell and reveal the underlying PACQ mechanism. Oxidation‐induced changes in Ce electronic configuration and local lattice environment weaken Ce‐mediated quenching and restore NIR‐II Nd(III) emission. Based on this mechanism, we further develop a ratiometric NaErF 4 :Yb@NaLuF 4 @NaCeF 4 :Nd nanoprobe (RPACQ), where the Er(III) emission provides a stable internal reference. RPACQ exhibits reversible H 2 O 2 /glutathione responses, with second‐scale activation, concentration‐dependent ratiometric responses in vitro, and excellent photostability. In a cerebral ischemia‐reperfusion injury (CIRI) model, RPACQ provides proof‐of‐concept for in vivo redox imaging. Collectively, this work establishes an intrinsic lanthanide nanoparticle strategy for reversible NIR‐II luminescence regulation without external molecular reporters, potentially opening new avenues for engineering responsive lanthanide nanomaterials.
- Open Access
- 14 October 2026
- Published by Wiley in Advanced Materials
- p. e75392
Synchronized Ablation of Multifocal Tumors Enabled by Multi‐Channel Lanthanide Nanocomposites
The multifocal nature of orthotopic breast tumors makes it difficult to treat due to individual tumor differences, requiring multiple therapeutic interventions. Here, a customized therapeutic strategy is presented for multiple tumors by using the same prescription based on a multi‐channel lanthanide nanocomposite and orthogonally controlled drug release. The upconversion luminescence of the nanocomposite at different wavelengths can monitor pH‐responsive mitoxantrone (MXT) release, reduced glutathione‐responsive near‐infrared (NIR) absorbance change, and eigen temperature, respectively, allowing modulation of photothermal treatment and temperature‐responsive paclitaxel release through customized whole‐body irradiation to achieve synchronized ablation of different individual tumors. Small animal experiments confirm multifocal breast tumors can be treated through this customized therapeutic strategy with both high efficiency and low overtherapy risk.
- 14 October 2026
- Published by Wiley in Advanced Materials
- p. e75392
Open AccessSynchronized Ablation of Multifocal Tumors Enabled by Multi‐Channel Lanthanide Nanocomposites
The multifocal nature of orthotopic breast tumors makes it difficult to treat due to individual tumor differences, requiring multiple therapeutic interventions. Here, a customized therapeutic strategy is presented for multiple tumors by using the same prescription based on a multi‐channel lanthanide nanocomposite and orthogonally controlled drug release. The upconversion luminescence of the nanocomposite at different wavelengths can monitor pH‐responsive mitoxantrone (MXT) release, reduced glutathione‐responsive near‐infrared (NIR) absorbance change, and eigen temperature, respectively, allowing modulation of photothermal treatment and temperature‐responsive paclitaxel release through customized whole‐body irradiation to achieve synchronized ablation of different individual tumors. Small animal experiments confirm multifocal breast tumors can be treated through this customized therapeutic strategy with both high efficiency and low overtherapy risk.
- Open Access
- 29 July 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (69) , e77355
Coprecipitation‐Assisted Sensitizer Assembly Enhanced NIR‐IIb Lanthanide Luminescence for RNAi Therapy Monitoring In Vivo
NIR‐IIb (1500–1700 nm) lanthanide imaging offers superior tissue penetration and spatial resolution for the real‐time monitoring of macromolecular drugs (MDs) delivery and controlled release in vivo, but were severely hindered by its low quantum yield. Herein, a coprecipitation‐assisted sensitizer assembly strategy is presented to build a high‐quantum‐yield NIR‐IIb lanthanide luminescence nanocomposite. Amorphous calcium phosphate/dicalcium phosphate (CaP) shell with IR‐806 molecules is coprecipitated on NaYF 4 @NaYbF 4 :Ca,Tm@CaF 2 nanoparticles (CaP‐Assembly), enabling 22‐fold enhancement in NIR‐IIb quantum yield (5.94% vs. 0.27% for lanthanide nanocrystals with IR‐806 only) and two orders of magnitude enhancement in NIR‐IIb luminescence intensity. The CaP shell mitigates non‐radiative energy loss in the lanthanide nanocrystals, and synergistically suppresses aggregation‐caused quenching (ACQ) and solvent‐induced quenching of dye molecules. In the bone defect model undergoing RNA interference (RNAi) therapy, HIF‐1α siRNA‐loaded CaP‐Assembly enabled the in vivo NIR‐IIb monitoring of the delivery and intracellular release of phosphate groups and nucleic acid drugs in the local monocytes/macrophages of the bone marrow.
- 29 July 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (69) , e77355
Open AccessCoprecipitation‐Assisted Sensitizer Assembly Enhanced NIR‐IIb Lanthanide Luminescence for RNAi Therapy Monitoring In Vivo
NIR‐IIb (1500–1700 nm) lanthanide imaging offers superior tissue penetration and spatial resolution for the real‐time monitoring of macromolecular drugs (MDs) delivery and controlled release in vivo, but were severely hindered by its low quantum yield. Herein, a coprecipitation‐assisted sensitizer assembly strategy is presented to build a high‐quantum‐yield NIR‐IIb lanthanide luminescence nanocomposite. Amorphous calcium phosphate/dicalcium phosphate (CaP) shell with IR‐806 molecules is coprecipitated on NaYF 4 @NaYbF 4 :Ca,Tm@CaF 2 nanoparticles (CaP‐Assembly), enabling 22‐fold enhancement in NIR‐IIb quantum yield (5.94% vs. 0.27% for lanthanide nanocrystals with IR‐806 only) and two orders of magnitude enhancement in NIR‐IIb luminescence intensity. The CaP shell mitigates non‐radiative energy loss in the lanthanide nanocrystals, and synergistically suppresses aggregation‐caused quenching (ACQ) and solvent‐induced quenching of dye molecules. In the bone defect model undergoing RNA interference (RNAi) therapy, HIF‐1α siRNA‐loaded CaP‐Assembly enabled the in vivo NIR‐IIb monitoring of the delivery and intracellular release of phosphate groups and nucleic acid drugs in the local monocytes/macrophages of the bone marrow.
- Open Access
- 20 January 2026
- Published by Wiley in Advanced Science
- Vol. 13 (16) , e16035
Alkaline Phosphatase‐Activated NIR‐II AIEgens Nanosystem for Surgical and Postoperative Closed‐Loop Therapy of Advanced Osteosarcoma
In advanced osteosarcoma, tumor invasion often prevents complete resection, and immunotherapy is limited by the tumor's immunosuppressive nature, making residual lesions a key source of recurrence. To address this, we developed an ALP‐responsive theranostic nanoplatform (SGPF) integrating an AIEgens (STEA) and HSP90 inhibitor (Ganetespib) for imaging‐guided resection and multimodal therapy. Selenium‐doped STEA enables NIR‐IIb imaging and enhanced phototherapy via narrowed HOMO‐LUMO gaps and nonradiative decay optimization. At tumor sites, ALP‐triggered nanomicelle cleavage releases STEA and Ganetespib while vaporizing perfluorohexane to relieve hypoxia. NIR irradiation induces pyroptosis via caspase‐3/GSDME activation and immunogenic cell death, while Ganetespib suppresses glycolysis (HK2/PKM2 downregulation) to reverse lactate‐driven immunosuppression. This dual‐action strategy synergistically enhances T‐cell infiltration and ablates residual/metastatic lesions, offering a transformative approach for unresectable Osteosarcoma.
- 20 January 2026
- Published by Wiley in Advanced Science
- Vol. 13 (16) , e16035
Open AccessAlkaline Phosphatase‐Activated NIR‐II AIEgens Nanosystem for Surgical and Postoperative Closed‐Loop Therapy of Advanced Osteosarcoma
In advanced osteosarcoma, tumor invasion often prevents complete resection, and immunotherapy is limited by the tumor's immunosuppressive nature, making residual lesions a key source of recurrence. To address this, we developed an ALP‐responsive theranostic nanoplatform (SGPF) integrating an AIEgens (STEA) and HSP90 inhibitor (Ganetespib) for imaging‐guided resection and multimodal therapy. Selenium‐doped STEA enables NIR‐IIb imaging and enhanced phototherapy via narrowed HOMO‐LUMO gaps and nonradiative decay optimization. At tumor sites, ALP‐triggered nanomicelle cleavage releases STEA and Ganetespib while vaporizing perfluorohexane to relieve hypoxia. NIR irradiation induces pyroptosis via caspase‐3/GSDME activation and immunogenic cell death, while Ganetespib suppresses glycolysis (HK2/PKM2 downregulation) to reverse lactate‐driven immunosuppression. This dual‐action strategy synergistically enhances T‐cell infiltration and ablates residual/metastatic lesions, offering a transformative approach for unresectable Osteosarcoma.
- 26 December 2025
- Published by Elsevier in Biomaterials
- Vol. 329, 123949
Ultrabirght organic nanocrystals by amphiphile-templated crystallization for high-contrast NIR-II bioimaging
- 26 December 2025
- Published by Elsevier in Biomaterials
- Vol. 329, 123949
Ultrabirght organic nanocrystals by amphiphile-templated crystallization for high-contrast NIR-II bioimaging
- Open Access
$μ$NeuFMT: Optical-Property-Adaptive Fluorescence Molecular Tomography via Implicit Neural Representation
Fluorescence Molecular Tomography (FMT) is a promising technique for non-invasive 3D visualization of fluorescent probes, but its reconstruction remains challenging due to the inherent ill-posedness and reliance on inaccurate or often-unknown tissue optical properties. While deep learning methods have shown promise, their supervised nature limits generalization beyond training data. To address these problems, we propose $μ$NeuFMT, a self-supervised FMT reconstruction framework that integrates implicit neural-based scene representation with explicit physical modeling of photon propagation. Its key innovation lies in jointly optimize both the fluorescence distribution and the optical properties ($μ$) during reconstruction, eliminating the need for precise prior knowledge of tissue optics or pre-conditioned training data. We demonstrate that $μ$NeuFMT robustly recovers accurate fluorophore distributions and optical coefficients even with severely erroneous initial values (0.5$\times$ to 2$\times$ of ground truth). Extensive numerical, phantom, and in vivo validations show that $μ$NeuFMT outperforms conventional and supervised deep learning approaches across diverse heterogeneous scenarios. Our work establishes a new paradigm for robust and accurate FMT reconstruction, paving the way for more reliable molecular imaging in complex clinically related scenarios, such as fluorescence guided surgery.Open Access$μ$NeuFMT: Optical-Property-Adaptive Fluorescence Molecular Tomography via Implicit Neural Representation
Fluorescence Molecular Tomography (FMT) is a promising technique for non-invasive 3D visualization of fluorescent probes, but its reconstruction remains challenging due to the inherent ill-posedness and reliance on inaccurate or often-unknown tissue optical properties. While deep learning methods have shown promise, their supervised nature limits generalization beyond training data. To address these problems, we propose $μ$NeuFMT, a self-supervised FMT reconstruction framework that integrates implicit neural-based scene representation with explicit physical modeling of photon propagation. Its key innovation lies in jointly optimize both the fluorescence distribution and the optical properties ($μ$) during reconstruction, eliminating the need for precise prior knowledge of tissue optics or pre-conditioned training data. We demonstrate that $μ$NeuFMT robustly recovers accurate fluorophore distributions and optical coefficients even with severely erroneous initial values (0.5$\times$ to 2$\times$ of ground truth). Extensive numerical, phantom, and in vivo validations show that $μ$NeuFMT outperforms conventional and supervised deep learning approaches across diverse heterogeneous scenarios. Our work establishes a new paradigm for robust and accurate FMT reconstruction, paving the way for more reliable molecular imaging in complex clinically related scenarios, such as fluorescence guided surgery. - 29 September 2025
- Published by Royal Society of Chemistry (RSC) in Materials Horizons
- Vol. 12 (19) , 8134-8146
Focused ultrasound-responsive artificial killer cells for enhanced closed-loop cancer immunotherapy
Focused ultrasound (FUS) responsive artificial killer cells (AKCs) overcome immunosuppressive tumor barriers via biomimetic engineering.
- 29 September 2025
- Published by Royal Society of Chemistry (RSC) in Materials Horizons
- Vol. 12 (19) , 8134-8146
Focused ultrasound-responsive artificial killer cells for enhanced closed-loop cancer immunotherapy
Focused ultrasound (FUS) responsive artificial killer cells (AKCs) overcome immunosuppressive tumor barriers via biomimetic engineering.
NIR‐II Emissive, Ischemia Targeted Nanocomposites for Localized Therapeutic Hypothermia of Cerebral Ischemia‐Reperfusion Injury
As the gold‐standard neuroprotective intervention against cerebral ischemia‐reperfusion injury, therapeutic hypothermia (TH) exhibits clinical efficacy while the current TH strategies are limited in application due to their non‐specific cooling effect causing severe side effects. Developing targeted TH strategies still remains a problem. In this work, a near infrared emissive, ischemic targeted nanocomposite is demonstrated to achieve localized TH at the ischemic‐reperfusion site. Rare earth doped nanoparticle as the core of the nanocomposite generates near infrared II luminescence for the guidance of delivery process. 2H,3H‐decafluoropentane and ammonium nitrate loaded in the mesoporous silica layer of the nanocomposite serve as physical and chemical cooling agents for temperature reduction in the brain. Surface ligands modified with stroke‐homing peptide and reactive oxygen species cleavable ketone moieties of the nanocomposite can target the inflammatory ischemic region and the promote cooling effects. By the intranasal administration of the nanocomposite in ischemic stroke mice model, infract area and pro‐inflammatory factors levels of the brain are effectively reduced and the neurological functions are preserved. This work points to a concept of localized hypothermia method via nanomaterials, which may inspire the development of TH therapy for stroke in the future.
NIR‐II Emissive, Ischemia Targeted Nanocomposites for Localized Therapeutic Hypothermia of Cerebral Ischemia‐Reperfusion Injury
As the gold‐standard neuroprotective intervention against cerebral ischemia‐reperfusion injury, therapeutic hypothermia (TH) exhibits clinical efficacy while the current TH strategies are limited in application due to their non‐specific cooling effect causing severe side effects. Developing targeted TH strategies still remains a problem. In this work, a near infrared emissive, ischemic targeted nanocomposite is demonstrated to achieve localized TH at the ischemic‐reperfusion site. Rare earth doped nanoparticle as the core of the nanocomposite generates near infrared II luminescence for the guidance of delivery process. 2H,3H‐decafluoropentane and ammonium nitrate loaded in the mesoporous silica layer of the nanocomposite serve as physical and chemical cooling agents for temperature reduction in the brain. Surface ligands modified with stroke‐homing peptide and reactive oxygen species cleavable ketone moieties of the nanocomposite can target the inflammatory ischemic region and the promote cooling effects. By the intranasal administration of the nanocomposite in ischemic stroke mice model, infract area and pro‐inflammatory factors levels of the brain are effectively reduced and the neurological functions are preserved. This work points to a concept of localized hypothermia method via nanomaterials, which may inspire the development of TH therapy for stroke in the future.